A Clinical trial to study the effect of the drug Kalladaippu Chooranam in patients having Kalladaippu (Urolithiasis)

An open Non-Randomized clinical trial of Kalladaippu Chooranam in Vatha Kalladaippu (Urolithiasis)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012767

Enrollment

Registered

2018-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- KALLADAIPPU (UROLITHIASIS)

Interventions

Intervention1: KALLADAIPPU CHOORANAM: 1 gram of Kalladaippu Chooranam is administrated twice a day with honey for 48 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1 Willing to participate in trial and signing in consent Proforma 2 Flank pain Lower abdominal pain Burning micturition 3 Nausea 4 Vomiting 5 Oliguria 6 Dysuria 7 Haematuria 8 Stone size 4 to 10 mm

Exclusion criteria

Exclusion criteria: 1 Age group less than 18 years and above 60 years 2 Hydronephrosis 3 Stag horn calculus 4 Calculi Associated with elevated serum creatinine level 5 Calculi in pregnancy

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction in clinical symptoms i.e,, Renal function test and USG for whole abdomen and by comparing before and after treatment and questionnairesTimepoint: 48 Days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Arulpriya S

Government Siddha Medical College

drkkanakavalli@gmail.com9444122865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026